BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37926169)

  • 21. Pre-operative Neurocognitive Function Was More Susceptible to Decline in Isocitrate Dehydrogenase Wild-Type Subgroups of Lower-Grade Glioma Patients.
    Zhang Z; Jin Z; Yang X; Zhang L; Zhang Y; Liu D; Chi X; Hao S; Feng J; Ji N
    Front Neurol; 2020; 11():591615. PubMed ID: 33363506
    [No Abstract]   [Full Text] [Related]  

  • 22. RICH2, a potential tumor suppressor in hepatocellular carcinoma.
    Zhang J; Yang C; Gong L; Zhu S; Tian J; Zhang F; Zhu Q; Wang J; Lan M; Li Y; Zhang W
    Front Biosci (Landmark Ed); 2019 Jun; 24(8):1363-1376. PubMed ID: 31136984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas.
    Carstam L; Corell A; Smits A; Dénes A; Barchéus H; Modin K; Sjögren H; Ferreyra Vega S; Bontell TO; Carén H; Jakola AS
    Front Oncol; 2021; 11():803975. PubMed ID: 35083156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.
    Halasz LM; Attia A; Bradfield L; Brat DJ; Kirkpatrick JP; Laack NN; Lalani N; Lebow ES; Liu AK; Niemeier HM; Palmer JD; Peters KB; Sheehan J; Thomas RP; Vora SA; Wahl DR; Weiss SE; Yeboa DN; Zhong J; Shih HA
    Pract Radiat Oncol; 2022; 12(5):370-386. PubMed ID: 35902341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates of Seizure Freedom After Surgical Resection of Diffuse Low-Grade Gliomas.
    Bonney PA; Boettcher LB; Burks JD; Baker C; Conner AK; Fujii T; Mehta VA; Briggs RG; Sughrue ME
    World Neurosurg; 2017 Oct; 106():750-756. PubMed ID: 28673890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
    Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
    J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparanase expression of glioma in human and animal models.
    Hong X; Nelson KK; deCarvalho AC; Kalkanis SN
    J Neurosurg; 2010 Aug; 113(2):261-9. PubMed ID: 19835469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of intracranial oligodendroglioma and astrocytoma of similar grades using conventional and T1-weighted DCE-MRI.
    Gupta M; Gupta A; Yadav V; Parvaze SP; Singh A; Saini J; Patir R; Vaishya S; Ahlawat S; Gupta RK
    Neuroradiology; 2021 Aug; 63(8):1227-1239. PubMed ID: 33469693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Stratification in Low Grade Glioma: A Single Institutional Experience.
    Keshri V; Deshpande RP; Chandrasekhar YBVK; Panigrahi M; Rao IS; Babu PP
    Neurol India; 2020; 68(4):803-812. PubMed ID: 32859817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical management of diffuse low-grade gliomas associated with other intracranial diseases.
    Vassal M; Rigau V; de Champfleur NM; Duffau H
    Acta Neurochir (Wien); 2014 Feb; 156(2):339-47. PubMed ID: 24292776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
    Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
    Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct metabolic hallmarks of WHO classified adult glioma subtypes.
    Björkblom B; Wibom C; Eriksson M; Bergenheim AT; Sjöberg RL; Jonsson P; Brännström T; Antti H; Sandström M; Melin B
    Neuro Oncol; 2022 Sep; 24(9):1454-1468. PubMed ID: 35157758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of folate receptor -α protein expression in human gliomas and its clinical relevance].
    Wu H; Zhan Y; Qu Y; Qi X; Li J; Yu C
    Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):202-7. PubMed ID: 24785460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
    Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of seizure outcomes in patients with diffuse low-grade glioma-related epilepsy after complete glioma removal.
    He X; Zhang K; Liu D; Yang Z; Li X; Yang Z
    CNS Neurosci Ther; 2023 Feb; 29(2):736-743. PubMed ID: 36514187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial network in glioma's invadopodia displays an activated state both in situ and in vitro: potential functional implications.
    Arismendi-Morillo G; Hoa NT; Ge L; Jadus MR
    Ultrastruct Pathol; 2012 Dec; 36(6):409-14. PubMed ID: 23216239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.
    Duffau H
    Acta Neurochir (Wien); 2016 Jan; 158(1):51-8. PubMed ID: 26530708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
    Jensen RL; Ragel BT; Whang K; Gillespie D
    J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.